- EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
- EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
- EQS-AFR: Sartorius AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
- EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
- EQS-DD: Sartorius AG: Dr. Florian Funck, Transfer of 1207 preference shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
- EQS-DD: Sartorius AG: Dr. Florian Funck, Transfer of 1500 ordinary shares as a share-based remuneration component in fulfillment of a grant made before the start of the Management Board mandate.
- EQS-News: Resolutions of the Annual General Meeting of Sartorius AG
More ▼
Key statistics
On Wednesday, Sartorius AG (SRT:STU) closed at 195.80, 8.66% above its 52-week low of 180.20, set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 192.80 |
---|---|
High | 197.60 |
Low | 191.80 |
Bid | 194.60 |
Offer | 200.00 |
Previous close | 190.40 |
Average volume | 283.67 |
---|---|
Shares outstanding | 74.88m |
Free float | 32.69m |
P/E (TTM) | 89.20 |
Market cap | 16.32bn EUR |
EPS (TTM) | 2.18 EUR |
Annual div (ADY) | 0.73 EUR |
---|---|
Annual div yield (ADY) | 0.38% |
Div ex-date | Apr 02 2024 |
Div pay-date | Apr 04 2024 |
Data delayed at least 15 minutes, as of Jun 05 2024.
More ▼